Lanean...
Extracellular vesicles as modifiers of antibody‐drug conjugate efficacy
Antibody‐drug conjugates (ADCs) are a new class of anti‐cancer drugs that consist of a monoclonal antibody, a highly potent small‐molecule cytotoxic drug, and a chemical linker between the two. ADCs can selectively deliver cytotoxic drugs to cancer cells leading to a reduced systemic exposure and a...
Gorde:
| Argitaratua izan da: | J Extracell Vesicles |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7881363/ https://ncbi.nlm.nih.gov/pubmed/33613875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jev2.12070 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|